Get alerted on the PharmaSources E-Newsletter and Pharma Sources Insight E-Compilation!
Note: You can unsubscribe from the alerts at any time.
Advertising

Johnson & Johnson reports that investigational Ebola vaccine regimen induced durable immune response

worldpharmanewsMarch 16, 2017

Tag: Johnson & Johnson , Ebola vaccine

PharmaSources Customer Service